详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

5| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究负责人：

研究单位： [1]Beiing Tongren hospital,Beijing,China,100730

关键词： bleb vascular change bevacizumab trabeculectomy Bleb vascularity associated with increased scarring activity Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva

研究目的：

The occurrence of conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery. Vascular endothelial growth factor is thought to be a key role in the formation of conjunctival scar, which play a pivotal role in the wound-healing process. So it seems that the recombinant human anti-VEGF antibody could inhibit angiogenesis, and reduce the conjunctival vascular formation in the wound-healing process after glaucoma filtering surgery.

资源点击量：23624 今日访问量：3 总访问量：1285 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题